Chris Hohn portfolio
Updated November 15, 2026
Chris Hohn (TCI Fund Management) — British manager with one of the best track records of the past decade, owning near-monopolies such as airports and Visa/Mastercard.
According to the latest 13F report that TCI Fund Management filed with the SEC (Q2 2026, filed August 14, 2026), its US stock portfolio is worth about $52.8B across 11 holdings. The largest positions are General ElectricGE, Visa Inc-class A SharesV, Moody's CorpMCO, and the top 10 make up 99% of the portfolio.
| # | Stock | Weight | Value | Change this quarter |
|---|---|---|---|---|
| 1 | General ElectricGE | 33.6% | $17.7B | — |
| 2 | Visa Inc-class A SharesV | 19.8% | $10.5B | — |
| 3 | Moody's CorpMCO | 12.3% | $6.5B | — |
| 4 | S&P Global IncSPGI | 10.9% | $5.7B | — |
| 5 | Canadian Pacific Kansas CityCP | 7.4% | $3.9B | Trimmed +3% |
| 6 | Alphabet Inc-cl CGOOG | 6.7% | $3.5B | Added +12% |
| 7 | Ferrovial NVFER | 2.7% | $1.4B | Added +1% |
| 8 | Canadian Natl Railway CoCNI | 2.1% | $1.1B | Trimmed +4% |
| 9 | Alphabet Inc-cl AGOOGL | 1.7% | $878M | — |
| 10 | Martin Marietta MaterialsMLM | 1.4% | $758M | New buy |
| 11 | Vulcan Materials CoVMC | 1.4% | $722M | New buy |
Positions sold out
Microsoft CorpMSFT
Frequently asked questions
What does Chris Hohn own now?
According to the latest 13F (Q2 2026), the largest holdings are General ElectricGE, Visa Inc-class A SharesV, Moody's CorpMCO. The full list is in the table above.
What is a 13F report?
US investment managers with more than $100 million in US stocks must list their holdings with the SEC within 45 days after each quarter ends.
Why is the data delayed?
Because 13F reports arrive up to 45 days after the quarter ends, the manager may have traded since then.
Should I copy this portfolio?
Knowing what great investors buy is a good source of ideas, but because of the delay and different goals, copying blindly is not recommended.
More lists and tools
Lists are generated automatically from SEC filings and market prices and rebuilt every day. They are a starting point for research, not a recommendation to buy or sell.